4.3 Review

Stimulation of anti-tumor immunity by photodynamic therapy

期刊

EXPERT REVIEW OF CLINICAL IMMUNOLOGY
卷 7, 期 1, 页码 75-91

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1586/ECI.10.81

关键词

anti-tumor immunity; cancer vaccines; cytotoxic T-lymphocytes; damage-associated molecular patterns; dendritic cells; photodynamic therapy; Toll-like receptor agonists; tumor-associated antigens

资金

  1. Partners Genzyme Translational Grant
  2. Swiss Science Foundation [205320-122144, IZLSZ2 _123011, 310030-119938, K-32K1-116460]
  3. NIH [R01AI050875]
  4. Center for Integration of Medicine and Innovative Technology [DAMD17-02-2-0006]
  5. CDMRP Program in TBI [W81XWH-09-1-0514]
  6. Air Force Office of Scientific Research [FA9950-04-1-0079]
  7. NATIONAL CANCER INSTITUTE [R01CA083882] Funding Source: NIH RePORTER
  8. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Photodynamic therapy (PDT) is a rapidly developing cancer treatment that utilizes the combination of nontoxic dyes and harmless visible light to destroy tumors by generating reactive oxygen species. PDT produces tumor-cell destruction in the context of acute inflammation that acts as a 'danger signal' to the innate immune system. Activation of the innate immune system increases the priming of tumor-specific T lymphocytes that have the ability to recognize and destroy distant tumor cells and, in addition, lead to the development of an immune memory that can combat recurrence of the cancer at a later point in time. PDT may be also successfully combined with immunomodulating strategies that are capable of overcoming or bypassing the escape mechanisms employed by the progressing tumor to evade immune attack. This article will cover the role of the immune response in PDT anti-tumor effectiveness. It will highlight the milestones in the development of PDT-mediated anti-tumor immunity and emphasize the combination strategies that may improve this therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据